Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Prostate Adenocarcinoma × Neoadjuvant Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 11 Rectal Neoplasms 9 Colorectal Neoplasms 7 Stomach Neoplasms 6 Esophageal Squamous Cell Carcinoma 6 Esophageal Neoplasms 6 Neoplasm Metastasis 4 Nasopharyngeal Carcinoma 4 Carcinoma, Non-Small-Cell Lung 4 Adenocarcinoma Of Esophagus 4 Uterine Cervical Neoplasms 3 Pancreatic Neoplasms 3 Neuroblastoma 3 Lung Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Prostatic Neoplasms 2 Peritoneal Neoplasms 2 Multiple Myeloma 2 Melanoma 2 Inflammatory Breast Neoplasms 2 Head and Neck Neoplasms 2 Fallopian Tube Neoplasms 2 Colonic Neoplasms 2 Central Nervous System Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Adenocarcinoma 2 Wilms Tumor 1 Uveal Melanoma 1 Stage III and IV Ovarian Cancer 1 Sarcoma 1

Interventions

Radiotherapy 1 Radiation Dose Hypofractionation 1 Radiation 1 Neoadjuvant Therapy 1 Adjuvants, Pharmaceutic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02175212 2020-11-20

AADLPC

Fundación de Investigación Biomédica - Hospital Universitario de La Princesa

Phase 3 Completed

362 enrolled 17 charts

Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡